Page last updated: 2024-08-16
pioglitazone and eye
pioglitazone has been researched along with eye in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Agnew, CE; Hamilton, PK; Harbinson, MT; Lockhart, CJ; McCann, AJ; McVeigh, GE; Millar, AM; Quinn, CE | 1 |
| Biagi, C; Marchesini, G; Marra, A; Motola, D; Piccinni, C; Poluzzi, E; Raschi, E | 1 |
Other Studies
2 other study(ies) available for pioglitazone and eye
| Article | Year |
|---|---|
Ocular blood flow analysis detects microvascular abnormalities in impaired glucose tolerance.
Topics: Adult; Aged; Blood Glucose; Eye; Fasting; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Microcirculation; Microvessels; Middle Aged; Pioglitazone; Thiazolidinediones | 2011 |
Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.
Topics: Adverse Drug Reaction Reporting Systems; Bone and Bones; Cardiovascular System; Clinical Trials as Topic; Databases, Factual; Eye; Female; Fractures, Bone; Humans; Hypoglycemic Agents; Macular Edema; Male; Meta-Analysis as Topic; Myocardial Infarction; Odds Ratio; Pioglitazone; Risk; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration | 2012 |